Back
ARS Pharmaceuticals Stock Price Chart
10 Best Stocks to Own in 2025
Get your copy now FREE!
Buy
72
SPRY
ARS Pharmaceuticals
Last Price:
$14.41
Seasonality Move:
20.39%
7 Day Trial
ALL ACCESS PASS
$
7
10 stocks to buy for the next leg of this rally
Get the full list here FREE-
The current trend is moderately bullish and SPRY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARS Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.66 | Buy |
| 20-day SMA: | 13.96 | Buy |
| 50-day SMA: | 13.69 | Buy |
| 200-day SMA: | 13.25 | Buy |
| 8-day EMA: | 14.63 | Buy |
| 20-day EMA: | 14.17 | Buy |
| 50-day EMA: | 13.65 | Buy |
| 200-day EMA: | 12.53 | Buy |
ARS Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 64.21 | Buy |
| Chaikin Money Flow: | 1429627 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.22 - 14.74) | Buy |
| Bollinger Bands (100): | (11.44 - 14.18) | Buy |
ARS Pharmaceuticals Technical Analysis
| May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ARS Pharmaceuticals Stock
Is ARS Pharmaceuticals Stock a Buy?
-
ARS Pharmaceuticals share price is 15.49 while SPRY 8-day simple moving average is 14.66, which is a Buy signal.
-
The stock price of SPRY is 15.49 while ARS Pharmaceuticals 20-day SMA is 13.96, which makes it a Buy.
-
ARS Pharmaceuticals 50-day simple moving average is 13.69 while SPRY share price is 15.49, making it a Buy technically.
-
SPRY stock price is 15.49 and ARS Pharmaceuticals 200-day simple moving average is 13.25, creating a Buy signal.
SPRY Technical Analysis vs Fundamental Analysis
Buy
72
ARS Pharmaceuticals (SPRY)
is a Buy
Is ARS Pharmaceuticals a Buy or a Sell?
-
ARS Pharmaceuticals stock is rated a BuyThe current ARS Pharmaceuticals [SPRY] share price is $15.49. The Score for SPRY is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
ARS Pharmaceuticals Stock Info
Market Cap:
1.5B
Price in USD:
15.49
Share Volume:
1.5M
ARS Pharmaceuticals 52-Week Range
52-Week High:
18.51
52-Week Low:
7.55
Buy
72
ARS Pharmaceuticals (SPRY)
is a Buy
ARS Pharmaceuticals Share Price Forecast
-
What is the ARS Pharmaceuticals stock price today?The ARS Pharmaceuticals stock price is 15.49 USD today.
-
Will SPRY stock go up or go down?ARS Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is ARS Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ARS Pharmaceuticals is not overvalued.
Is ARS Pharmaceuticals Stock a Buy?
-
ARS Pharmaceuticals share price is 15.49 while SPRY 8-day exponential moving average is 14.63, which is a Buy signal.
-
The stock price of SPRY is 15.49 while ARS Pharmaceuticals 20-day EMA is 14.17, which makes it a Buy.
-
ARS Pharmaceuticals 50-day exponential moving average is 13.65 while SPRY share price is 15.49, making it a Buy technically.
-
SPRY stock price is 15.49 and ARS Pharmaceuticals 200-day simple moving average is 12.53, creating a Buy signal.
Fundamental Analysis of ARS Pharmaceuticals
Is ARS Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, an increase next quarter of $0.16 per share, a decrease this year of $0.99 per share, and an increase next year of $0.83 per share.
Technical Analysis of ARS Pharmaceuticals
Should I short ARS Pharmaceuticals stock?
-
SPRY Moving Average Covergence Divergence (MACD) indicator is 0.36, suggesting ARS Pharmaceuticals is a Buy
-
ARS Pharmaceuticals Relative Strength Index (RSI) is 64.21, which suggest ARS Pharmaceuticals is overbought
-
The Bollinger Bands (25) for ARS Pharmaceuticals is (13.22 - 14.74), which suggest ARS Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for ARS Pharmaceuticals is (11.44 - 14.18), which suggest ARS Pharmaceuticals is a Buy
* ARS Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.